Skip to main content
Premium Trial:

Request an Annual Quote

Concerns Over Variant Found in California

Initial analyses indicate a SARS-CoV-2 variant uncovered in California may both be more transmissible and partially evade vaccine-induced antibody response, the Los Angeles Times reports.

The variant, dubbed B.1.427/B.1.429, began to rise in frequency in the state in September to now account for about half of all COVID-19 cases that have undergone sequencing there, and the University of California, San Francisco's Charles Chiu predicts at the LA Times it may represent 90 percent of cases in California by the end of March. 

According to the paper, Chiu and a team of researchers analyzed viral samples from various California counties in work that is to be posted to MedRxiv. Their analysis, it says, suggests B.1.427/B.1.429 is between 19 percent and 24 percent more transmissible. Further, lab-based tests suggest that the L452R mutation it has that affects its spike protein enables the virus to better bind to host cells, the LA Times reports. At the same time, it says other lab tests also indicated that B.1.427/B.1.429 elicits a lower neutralizing antibody response following vaccination or previous infection. 

The paper adds that the B.1.427/B.1.429 variant has also been tied to increased severe illness and death, though that could in part be due to overwhelmed hospitals.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.